4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate,
BAY 43 9006,
BAY 43-9006,
BAY 439006,
BAY 545 9085,
BAY 545-9085,
BAY 5459085,
BAY 673472,
BAY-545-9085,
BAY-673472,
BAY5459085,
Nexavar,
sorafenib,
Sorafenib N Oxide,
sorafenib N-oxide,
sorafenib tosylate,
Sorafenib N-Oxide,
583840-03-3,
UNII-5XYK65KIGD,
Sorafenib major metabolite,
5XYK65KIGD,
SCHEMBL548256,
CTK8E8479,
DTXSID60431376,
ZINC3817152,
RT-015755,
FT-0674634,
4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide 1-Oxide,
CID9826472,
CID 9826472,